Il trattamento di ematologia oncologica in Israele costa solitamente tra $2,200 e $240,000. I prezzi variano in base alla diagnosi specifica, alla complessità del protocollo di trattamento e alla tipologia della struttura, pubblica o privata. I pazienti internazionali riscontrano spesso risparmi del 30-80% rispetto agli Stati Uniti per procedure avanzate.
Costi tipici dell'ematologia oncologica in Israele
I principali centri medici situati a Tel Aviv, Ramat Gan e Gerusalemme sono all'avanguardia nel campo delle cure oncologiche specializzate. Sebbene i costi del trattamento siano generalmente uniformi in questi poli, i centri privati di Tel Aviv potrebbero presentare differenze nella struttura dei prezzi. Consulti uno specialista per ottenere una quotazione accurata per le sue specifiche esigenze mediche.
| Israele | Turchia | Austria | |
| Trapianto di midollo osseo allogenico da donatore non correlato | da $135,000 | da $80,000 | da $180,000 |
| Trapianto di midollo osseo allogenico da donatore consanguineo | da $142,000 | da $65,000 | da $150,000 |
| Trapianto di midollo osseo | da $135,000 | da $36,000 | da $140,000 |
| Terapia con cellule CAR-T | da $72,000 | da $150,000 | da $350,000 |
| Plasmaferesi | da $2,200 | da $1,200 | da $2,000 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Ematologia Oncologia. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Ematologia Oncologia e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento di procedure di Ematologia Oncologia.
Dr. Ron Ram is board-certified in Internal Medicine, Hematology, and Medical Oncology. He completed his residency at the State University of New York at Brooklyn. He also finished a fellowship in Hematology and Oncology at New York Medical College, Westchester Medical Center.
Dr. Ram has performed several hundred stem cell transplants. This shows his strong expertise in the field. He has published over 30 articles in peer-reviewed journals. He has also contributed a chapter to a medical textbook. These achievements reflect his commitment to research and education.
Dr. K.K. Iswaran is a highly experienced Obstetrician and Gynaecologist with 25+ years of experience in Obstetrics & Gynaecology Reproduction Medicine, IUI - Intrauterine Insemination, Ovulation Induction Procedure, Ovarian Drilling (Multiperforation), Urethral Valves, and more. He holds a Fellowship, Diploma, and MBBS from the Ronald O Perelman and Claudia Cohen Centre, Ireland, and the University of Mysore, India respectively.
Dr. Ronit El Hasid is the Head of Pediatric Oncohematology and Oncology at Dana Dwek Children’s Hospital (Sourasky). She specializes in bone marrow and umbilical blood transplantation and has conducted over 300 transplantations and published 50 papers and 40 reports. She is a member of American Association for Hematology and Israeli Society for Pediatric Hematooncology, and has previously practiced in the City of Hope Hospital (Los-Angeles) and other medical centers in Israel.
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.
Consult our guidelines.
` * **Traduzione:** `Consulta le nostre linee guida.
` Attendo il testo da tradurre.Tutti i contenuti medici di questa pagina sono redatti da autori con formazione medica specializzata e revisionati da medici certificati nel campo pertinente. Revisione medica da parte di Fahad Mawlood, Editor medico e Data Scientist.
Ultimo aggiornamento: April, 2026.
Tutti i dati sono forniti solo a scopo informativo generale e potrebbero non riflettere risultati o esperienze individuali.